In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDI™for all indicationsmatching the reference product ...

In addition to AVT06, which is a biosimilar candidate for Eylea ® (aflibercept) 2 mg, Alvotech is currently also developing AVT29, a biosimilar candidate for Eylea ® HD (aflibercept) 8 mg. Teva also ...

Update on USFDA Inspection at Company''s manufacturing facility in Virgonagar, Bengaluru, India ...

The logo of Google LLC is shown on a building in ... Google’s Chief People Officer, Fiona Cicconi, informed employees that the company would no longer maintain its ‘’aspirational hiring ...

As part of its global expansion strategy, the company continues to bolster its footprint across the Gulf countries, particularly in Saudi Arabia, where its presence has grown exponentially over ...

Top Indian drugmaker Sun Pharma's Q3 profit beats estimates on strong local sales January 31, 2025 Cipla , one of ... and Nicotinell acquisition, the company said on Tuesday.

Cipla Q3 results review: The shares of the third largest pharmaceutical firm Cipla rose 2.44 per cent at Rs 1,454.20 a piece on the BSE intraday after the company delivered a solid quarterly earnings ...

Cipla has been helping extend the reach of affordable life-saving HIV/AIDS medications since 2001. The company supplies antiretroviral (ARV) medicines to 64 countries by mostly participating in the ...

Earnings Today: Several companies are set to announce their quarterly earnings on January 28, including Bajaj Auto, BHEL, Bosch, CG Power and Industrial Solutions, Cipla, Colgate Palmolive, CSB Bank, ...

Cipla's stock settled 2.2% higher at ₹1,427 on Tuesday on the National Stock Exchange. The company expects to launch its breast cancer drug Abraxane, which was originally slated for a rollout in ...

Cipla Q3 Results: Pharmaceutical major Cipla on Tuesday reported a 49 per cent year-on-year (YoY) increase in its consolidated net profit for the December quarter (Q3 FY25) at Rs 1,574.6 crore, from ...

Team India star pacer was announced as the ICC Cricketer of the Year 2024 for his remarkable performances in the year bygone as he spearheaded the men in blues’ challenges across formats. The seamer ...